Wenfei Zhu1, Virginia G Wadley, Virginia J Howard, Brent Hutto, Steven N Blair, Steven P Hooker. 1. 1School of Physical Education, Shaanxi Normal University, Xi'an, Shaanxi, CHINA; 2Department of Medicine, School of Medicine, University of Alabama at Birmingham, Birmingham, AL; 3Department of Epidemiology, School of Public Health, University of Alabama at Birmingham, Birmingham, AL; 4Prevention Research Center, Arnold School of Public Health, University of South Carolina, Columbia, SC; 5Departments of Exercise Science and Epidemiology/Biostatistics, Arnold School of Public Health, University of South Carolina, Columbia, SC; and 6Exercise Science and Health Promotion Program, College of Health Solutions, Arizona State University, Phoenix, AZ.
Abstract
PURPOSE: Emerging evidence suggests physical activity (PA) is associated with cognitive function. To overcome limitations of self-report PA measures, this study investigated the association of accelerometer-measured PA with incident cognitive impairment and longitudinal cognition among older adults. METHODS: Participants were recruited from the cohort study Reasons for Geographic and Racial Differences in Stroke in the United States. Accelerometers provided PA measures, including the percentage of total accelerometer wearing time spent in moderate-to-vigorous-intensity PA (MVPA%), light-intensity PA, and sedentary time for four to seven consecutive days at baseline. Cognitive impairment was defined by the Six-Item Screener. Letter fluency, animal fluency, word list learning, and Montreal Cognitive Assessment (orientation and recall) were conducted to assess executive function and memory. RESULTS: Participants (N = 6452, 69.7 ± 8.5 yr, 55.3% women, 30.5% Black) with usable accelerometer and cognition measures spent extremely limited time in MVPA (1.5% ± 1.9% of accelerometer wearing time). During an average of 3 yr of follow-up, 346 cases of incident cognitive impairment were observed. After adjustments, participants in higher MVPA% quartiles had a lower risk of cognitive impairment (i.e., quartile 2: odds ratio = 0.64, 95% confidence interval = 0.48-0.84) and better maintenance in executive function (≥0.03 z-score units) and memory (≥0.12 z-score units) compared with quartile 1 (P < 0.05). Stratified analyses showed the same association among White adults, but higher MVPA% was associated with better maintenance of only memory among Black adults. No significance was found for light-intensity PA or sedentary time. CONCLUSION: There was a dose-response relationship between MVPA% and cognitive function in older adults, with higher levels associated with a 36% or lower risk of cognitive impairment and better maintenance of memory and executive function over time, particularly in White adults.
PURPOSE: Emerging evidence suggests physical activity (PA) is associated with cognitive function. To overcome limitations of self-report PA measures, this study investigated the association of accelerometer-measured PA with incident cognitive impairment and longitudinal cognition among older adults. METHODS:Participants were recruited from the cohort study Reasons for Geographic and Racial Differences in Stroke in the United States. Accelerometers provided PA measures, including the percentage of total accelerometer wearing time spent in moderate-to-vigorous-intensity PA (MVPA%), light-intensity PA, and sedentary time for four to seven consecutive days at baseline. Cognitive impairment was defined by the Six-Item Screener. Letter fluency, animal fluency, word list learning, and Montreal Cognitive Assessment (orientation and recall) were conducted to assess executive function and memory. RESULTS:Participants (N = 6452, 69.7 ± 8.5 yr, 55.3% women, 30.5% Black) with usable accelerometer and cognition measures spent extremely limited time in MVPA (1.5% ± 1.9% of accelerometer wearing time). During an average of 3 yr of follow-up, 346 cases of incident cognitive impairment were observed. After adjustments, participants in higher MVPA% quartiles had a lower risk of cognitive impairment (i.e., quartile 2: odds ratio = 0.64, 95% confidence interval = 0.48-0.84) and better maintenance in executive function (≥0.03 z-score units) and memory (≥0.12 z-score units) compared with quartile 1 (P < 0.05). Stratified analyses showed the same association among White adults, but higher MVPA% was associated with better maintenance of only memory among Black adults. No significance was found for light-intensity PA or sedentary time. CONCLUSION: There was a dose-response relationship between MVPA% and cognitive function in older adults, with higher levels associated with a 36% or lower risk of cognitive impairment and better maintenance of memory and executive function over time, particularly in White adults.
Authors: Robert Winker; Ina Lukas; Thomas Perkmann; Helmut Haslacher; Elisabeth Ponocny; Johann Lehrner; Dimiter Tscholakoff; Peter Dal-Bianco Journal: Wien Klin Wochenschr Date: 2010-11-15 Impact factor: 1.704
Authors: Miriam E Nelson; W Jack Rejeski; Steven N Blair; Pamela W Duncan; James O Judge; Abby C King; Carol A Macera; Carmen Castaneda-Sceppa Journal: Med Sci Sports Exerc Date: 2007-08 Impact factor: 5.411
Authors: Virginia J Howard; Mary Cushman; Leavonne Pulley; Camilo R Gomez; Rodney C Go; Ronald J Prineas; Andra Graham; Claudia S Moy; George Howard Journal: Neuroepidemiology Date: 2005-06-29 Impact factor: 3.282
Authors: Virginia G Wadley; Frederick W Unverzagt; Lisa C McGuire; Claudia S Moy; Rodney Go; Brett Kissela; Leslie A McClure; Michael Crowe; Virginia J Howard; George Howard Journal: Ann Neurol Date: 2011-05-26 Impact factor: 10.422
Authors: Richard P Troiano; David Berrigan; Kevin W Dodd; Louise C Mâsse; Timothy Tilert; Margaret McDowell Journal: Med Sci Sports Exerc Date: 2008-01 Impact factor: 5.411
Authors: J C Morris; A Heyman; R C Mohs; J P Hughes; G van Belle; G Fillenbaum; E D Mellits; C Clark Journal: Neurology Date: 1989-09 Impact factor: 9.910
Authors: Yonas E Geda; Rosebud O Roberts; David S Knopman; Teresa J H Christianson; V Shane Pankratz; Robert J Ivnik; Bradley F Boeve; Eric G Tangalos; Ronald C Petersen; Walter A Rocca Journal: Arch Neurol Date: 2010-01
Authors: B M Brown; J J Peiffer; H R Sohrabi; A Mondal; V B Gupta; S R Rainey-Smith; K Taddei; S Burnham; K A Ellis; C Szoeke; C L Masters; D Ames; C C Rowe; R N Martins Journal: Transl Psychiatry Date: 2012-11-20 Impact factor: 6.222
Authors: Pariya L Fazeli; Amanda L Willig; Vitor Oliveira; Thomas W Buford; David E Vance; Greer Burkholder; Heidi M Crane; Christine Horvat Davey; Julia Fleming; Allison R Webel Journal: AIDS Behav Date: 2022-09-27
Authors: Zvinka Z Zlatar; Chelsea C Hays; Zoe Mestre; Laura M Campbell; M J Meloy; Katherine J Bangen; Thomas T Liu; Jacqueline Kerr; Christina E Wierenga Journal: Exp Gerontol Date: 2019-08-02 Impact factor: 4.032
Authors: Shannon Halloway; Klodian Dhana; Pankaja Desai; Puja Agarwal; Thomas Holland; Neelum T Aggarwal; Jordi Evers; Frank M Sacks; Vincent J Carey; Lisa L Barnes Journal: J Gerontol A Biol Sci Med Sci Date: 2021-10-13 Impact factor: 6.053
Authors: Victoria Fleming; Brianna Piro-Gambetti; Austin Patrick; Matthew Zammit; Andrew Alexander; Bradley T Christian; Benjamin Handen; Annie Cohen; William Klunk; Charles Laymon; Beau M Ances; David T Plante; Ozioma Okonkwo; Sigan L Hartley Journal: Neurobiol Aging Date: 2021-07-29 Impact factor: 4.673